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Abstract
Characterization of metabolites and microbiota composition from human stool provides
powerful insight into the molecular phenotypic difference between subjects with normal
weight and those with overweight/obesity. The aim of this study was to identify potential
metabolic and bacterial signatures from stool that distinguish the overweight/obesity state
in children/adolescents. Using 1H NMR spectral analysis and 16S rRNA gene profiling, the
fecal metabolic profile and bacterial composition from 52 children aged 7 to 16 was evalu-
ated. The children were classified into three groups (16 with normal-weight, 17 with over-
weight, 19 with obesity). The metabolomic analysis identified four metabolites that were
significantly different (p < 0.05) among the study groups based on one-way ANOVA test-
ing: arabinose, butyrate, galactose, and trimethylamine. Significantly different (p < 0.01)
genus-level taxa based on edgeR differential abundance tests were genus Escherichia
and Tyzzerella subgroup 3. No significant difference in alpha-diversity was detected
among the three study groups, and no significant correlations were found between the sig-
nificant taxa and metabolites. The findings support the hypothesis of increased energy har-
vest in obesity by human gut bacteria through the growing observation of increased fecal
butyrate in children with overweight/obesity, as well as an increase of certain monosaccha-
rides in the stool. Also supported is the increase of trimethylamine as an indicator of an
unhealthy state.
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O, Nichols B, Vodolánová L, et al. (2021) Stool
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Introduction
The proportion of children and adolescents aged 5 to 19 considered overweight has risen glob-
ally from approximately 1 in 10 in the mid-1970s to about to about 1 in 5 in 2016 [1]. There is
strong evidence of a close relationship between childhood overweight/obesity and multiple
comorbidities which, collectively, reduce life expectancy and increase mortality. This has
become an emerging public health problem that has attracted the wide attention of researchers
[2–4]. Identifying potential biomarkers in pediatric populations via metabolomics and 16S
rDNA profiling can provide an opportunity not only to identify these conditions, but to find
potential prevention and treatment approaches.
Despite inter-individual differences, approaches using 16S rRNA gene amplicon
sequencing (16S rDNA profiling) of fecal samples have shown differing gut bacterial com-
position between children with obesity and those without [5]. For example, at the phylum
level, a high Firmicutes/ Bacteroidetes ratio (decrease in Bacteroidetes, increase in Firmi-
cutes) has been associated with obesity [6–8], and even specific strains such as F. prausnitzii
have been positively correlated with BMI z-score [8]. Nevertheless, there is inconsistency in
these observations and knowledge about the specific gut microbiota members relevant to
the characterization of overweight/obesity remain elusive [6, 9, 10]. Furthermore, micro-
biome studies have thus far tended to focus on adult populations; consequently, composi-
tional and functional differences between children and adult cohorts have not been
reported [11].
Although powerful, 16S rDNA profiling falls short in telling us about the functional
activities of the gut microbiota [12]. Another omics approach that helps fill this void is
metabolomics. Fecal metabolomics in particular reports on the interaction between host,
diet, and the microbiota, thus complementing 16S profiling by providing a functional read-
out of the microbiota [12, 13] and thus providing a characterization of the molecular pheno-
type [14–16]. Metabolomic studies have observed certain metabolic patterns and signatures
as potential biomarkers of obesity. For example, studies using various biofluids have
observed that an increased level of branched-chain amino acids (valine, leucine, isoleucine)
and of aromatic amino acids (tyrosine, tryptophan, phenylalanine, methionine) appear to
characterize the presence, and, in some cases, the propensity for obesity [2, 17, 18]. Never-
theless, further research is necessary to test whether proposed biomarker metabolites can be
considered an established and specific metabolic signature [17]. Furthermore, it is impor-
tant to differentiate metabolomic profile differences between children and adults; for exam-
ple, one striking observed difference in childhood obesity in contrast to adult obesity is that
impairment of fasting glucose levels is usually absent and, if present, it is a delayed finding
[2]. A recent example integrating 16S rDNA profiling and metabolomics observed that
67.7% of the fecal metabolome variance was explained by the gut microbiota composition
[12] and it has been widely observed that changes in metabolite levels are often associated
with the microbiota [2, 5, 17, 19]. This high degree of association between the microbiota
and the fecal metabolome makes integration of these two omics technologies a powerful
investigative strategy.
This study integrates these two omics approaches. Using stool samples as the analytical
matrix and an untargeted approach, we aimed to uncover potential metabolomic and gut
bacterial biomarkers of childhood overweight/obesity in a group of 52 Czech children/ado-
lescents aged 7 to 16 years. The analytical platforms used were 1H NMR to evaluate the meta-
bolomic profile and 16S rRNA gene sequencing to assess the gut bacteria composition. The
significant results from each were then correlated to better define metabolome-gut bacteria
relations.
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Methods
Study participants
This is an observational study to characterize differences in the stool metabolome and bacter-
iome among 52 Czech youth (28 females, 24 males) aged 7 to 16 years classified into three
comparison groups (normal-weight, overweight, and obese). The study was performed accord-
ing to the Declaration of Helsinki and was approved by the Ethical Committee of the Univer-
sity Hospital Královské Vinohrady, reference number LEK-VP / 01/0/2018. All participants
and their parents agreed to participate by signing appropriate written informed consents.
These written informed consents were provided by the parents for the participation of their
children in the study. The inpatient study took place during an eight-week period between late
July to late September 2018.
Participant recruitment was carried out by the Olivova Children’s Medical Institution (Oli-
vova Dětská Léčebna) in Řı́čany, Czech Republic, from their then-present patient population.
Recruitment criteria consisted of youth who were between 6 and 18 years of age, had no antibi-
otic intake for the past three months, were not currently taking any medication, and were
physically healthy to take part in a physical activity program led by physiotherapists focused
on aerobic activity, strengthening, and stretching twice a day on weekdays. The subjects con-
sidered overweight and obese were under treatment/rehabilitation of their overweight/obesity
condition through diet and physical activity. The control group (normal weight) were youth
with either a respiratory disease (chronic upper and lower respiratory cataracts, bronchial
asthma, allergies) or with an orthopedic diagnosis (scoliosis, poor posture, patients after sur-
gery). To minimize the potential of these conditions being confounding, those with a respira-
tory disease had to be in remission (not in an acute stage) whose only treatment was
climatotherapy and respiratory physiotherapy. Those with an orthopedic diagnosis were also
only receiving physiotherapy. Out of 121 identified youth who met these conditions, 52 of
them ultimately agreed (along with their parents) and/or completed the entire study process.
Once in the study, all participants were interned at Olivova for an eight-week period during
which they underwent a similar physical activity regime and all received a similar diet (same
ingredients, same dishes). The portion size for each participant was based on their age, gender,
and weight. Those classified as overweight/obese received 30% less kilocalories than recom-
mended for their age and gender, thus placing them on a caloric restriction. It is important to
note that the diet was planned by a clinical dietitian, the meals and snacks were prepared by
the Olivova cafeteria kitchen, and the composition of each meal (kilocalories, macronutrient
composition) was known as determined by the disaggregated ingredients of each meal through
the use of the Nutriservis Profi software (https://nutriservis.cz), a database of approximately
5000 ingredients, including over 900 Czech ones. There were three main meals provided
(breakfast, lunch, dinner) plus two snacks throughout the day. The meals were based on reci-
pes and foods typically eaten in a standard Czech school and home diet, thus, except for por-
tion control, the meals did not represent an adjustment for most participants. Although the
participants and their families agree to comply with the diet, potential leftover food and/or
additional intake of other items outside the provided meals could not be accounted for. On
average, the meals were composed of approximately 17% protein, 28% fat and 55% carbohy-
drates. This is a study period average, thus daily percentages were different. Participants were
not all sampled at the same time, but throughout the study period with the earliest collections
taking place after at least one week of habituation to the prescribed diet. As a result of the selec-
tion criteria, a similar physical activity regime, a homogenous diet among the participants, and
the same ethnic and geographic background of the participants, the effects of cofounding vari-
ables were minimized.
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The participants‘ body mass index (BMI) standard deviation score (z-score) was derived
from age-specific and sex-specific parameters from the Czech National Institute of Public
Health [20]. Based on World Health Organization’s guidelines [21], these data were used to
classify them into three categories: with obesity (OB) Z-scores > 2.00, with overweight (OW)
Z-scores > 1.00, and with normal (N) Z-scores� 1.00 and� -2.00. In total, 16 classified with
normal-weight (N), 17 with overweight (OW), and 19 with obesity (OB). Table 1 displays, per
each of the three study groups, the size, gender, as well as the mean (± standard deviation) for
the age, body mass index (BMI), BMI z-score, and the dietary percent macronutrient composi-
tion and kilocalorie content one day prior (D-1) and two days prior (D-2) the date of sampling.
S1 Table provides similar data per each participant.
Sample collection
Stool sample collection was carried out by the child/adolescents themselves after proper
instruction of the use of a disposable kit that consisted of a paper collection surface from
which approximately 1 g of stool was collected with a plastic spoon and deposited into a plastic
vial. The sample was then given to a nurse and stored at—20 ˚C until it was transported to the
analysis lab where it was stored at -80 ˚C until the time of the analysis.
After thawing, three stool aliquots of approximately 200 mg were placed into three 1.5 mL
microcentrifuge tubes. One aliquot was lyophilized to estimate the water content. No water
content was reported for two N samples, and for three OB samples. These values were then
used to normalize metabolite concentrations to water content as described in the statistics sec-
tion. The other two aliquots were used for the NMR (metabolomic) and 16S rDNA sequencing
analysis. Metabolomic analysis was applied to all 52 samples while 16S rDNA profiling was
carried out in 47 samples due to insufficient sample amount (2 from the N and 3 from the OW
group).
Metabolomic analysis
NMR sample preparation and processing. After thawing the aliquot from the 1.5 mL
microcentrifuge tube, 600 μL of ultrapure water was added. This was then vortexed (3000 rpm,
Table 1. Characteristics of the participants per study group (N, OW, OB).
N OW OB p-valuea
n 16 17 19 -
Gender M = 7, F = 9 M = 6, F = 11 M = 11, F = 8 -
Age (years) 11.06 (± 2.46) 11.47 (± 2.24) 10.47 (± 2.37) 0.45
BMI (kg/m2) 18.05 (± 2.45) 23.93 (± 3.10) 30.17 (± 4.28) < 0.01
BMI z-score 0.07 (± 0.80) 1.53 (± 0.29) 2.37 (± 0.23) < 0.01
% Carb. D-1 64.06 (± 5.09) 63.33 (± 3.93) 64.02 (± 4.32) 0.87
% Prot. D-1 18.51 (± 1.70) 19.55 (± 1.68) 19.12 (± 2.07) 0.29
% Fat D-1 17.43 (± 4.93) 17.11 (± 3.12) 16.86 (± 3.78) 0.92
% Carb. D-2 66.46 (± 3.18) 65.13 (± 6.64) 64.96 (± 5.89) 0.69
% Prot. D-2 18.29 (± 4.26) 21.00 (± 3.83) 19.43 (± 2.18) 0.10
% Fat D-2 15.25 (± 3.24) 13.88 (± 4.87) 15.61 (± 4.66) 0.48
kcal D-1 2224.80 (± 309.28) 1574.96 (± 154.58) 1565.42 (± 137.60) < 0.01
kcal D-2 2066.15 (± 322.74) 1533.68 (± 129.93) 1553.61 (± 77.66) < 0.01
M = male, F = female; values reported as mean (± standard deviation); D-1 = one day prior to sampling; D-2 = two days prior to sampling.
a. p-value based on one-way ANOVA test.
https://doi.org/10.1371/journal.pone.0247378.t001
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10sec) and centrifuged (17000 xg, 10 min) using a fixed angle rotor. The resulting supernatant
(540 μL) was transferred to another 1.5 mL microcentrifuge tube, and 60 μL of phosphate buff-
ered saline (PBS, 1.5 M K2HPO4 / 1.5 M NaH2PO4, 5 mM 3-(trimethylsilyl)-2,2,3,3-tetradeu-
teropropionic acid (TSP) + D2O, 0.2% NaN3, pH 7.4) solution was added. The sample was
then centrifuged (17000 xg, 10 min) using a fixed angle rotor. The resulting supernatant (500
to 550 μL) was transferred to a 5 mm NMR tube and introduced into an NMR spectrometer
for analysis.
NMR spectroscopy. 1H NMR spectra were recorded on a 500.23 MHz Bruker Avance III
spectrometer at a temperature of 298 K, equipped with a BBFO SmartProbe™ with Z-axis gra-
dients and a 24 slot autosampler (Bruker Biospin, Germany). A standard Bruker noesypr1d
(90˚-t1-90˚-dmix-90˚-FID) sequence was used to suppress signals from water molecules,
where t1 is a 4 μs delay time and dmix is the mixing time (0.1 s). Acquisition parameters for
the spectra were 128 scans, a 16 ppm spectral width collected into 32K data points, an acquisi-
tion time of 4 s, and an interscan relaxation delay of 5 s. Automatic routine including tuning,
3D shimming, 90˚pulse calibration and automatic receiver gain setting was run prior to each
sample.
NMR data processing and analysis. The Free Induction Decay (FID) obtained were zero-
filled to 64 k, Fourier-transformed, manually phased, and baseline corrected and referenced to
TSP:0 ppm using TopSpin 3.1 software (Bruker Biospin, Rheinstetten, Germany).
Multivariate analysis (MVA) was carried out via a chemometric approach. The spectra were
further manually phased and baseline corrected manually using Whittaker smoother algo-
rithm in MestreNova NMR Suite software package (Ver. 6.0.2, Mestrelab Research, S.L.,
Spain). Spectra between δ 9.0–0.0 ppm (excluding the residual water region, δ 5.1–4.6 ppm)
were reduced into consecutive, non-overlapping bins (buckets) of equal 0.04 ppm widths. Bins
were integrated and normalized based on the total sum of the spectral integral. Unsupervised
principal component analysis (PCA), and supervised partial least squares discriminant analysis
(PLS-DA) were applied to the normalized bins using MetaboAnalyst 3.0 (http://www.
metaboanalyst.ca) [22, 23] under the following parameters: no data filtering, sum normaliza-
tion, no data transformation, pareto scaling. The PLS-DA model was evaluated using a 10-fold
cross-validation.
Univariate analysis (UVA) was carried out using a quantitative (deconvolution) approach.
Using Chenomx NMR Suite (version 7.5, Chenomx Inc., Edmonton, Canada), fourier-trans-
formed spectra were subject to line broadening of 0.3 Hz, followed by further phase and base-
line manual correction. Metabolites were identified via the Chenomx Profiler library, the
Human Metabolome Database (http://www.hmdb.ca), and the literature. The metabolite con-
centrations in mg/dL from Chenomx were adjusted for the sample dilution. Using the individ-
ual sample wet weight (g) the concentrations were converted to mg/g, then normalized by the
mean water content of the entire data set, and finally Log2 transformed to prevent the domi-
nance of higher abundance metabolites, to decrease the skewness of the data, and to approxi-
mate a more normal distribution. Under the hypothesis that there was no significant
difference among the three study groups, a one-way analysis of variance (one-way ANOVA)
was applied (p< 0.05, two-tailed) to the Log2 transformed concentrations. The test accounted
for Levene’s test for equality of variances and used Tukey’s HSD as a post-hoc procedure. For
comparison, the false discovery rate (FDR) was also evaluated. Afterwards, Log 2 transformed
concentrations of the resulting significant metabolites, after removal of outliers using Tukey’s
method (above and below 1.5�IQR), were evaluated for the presence and direction of a linear
relationship between each metabolite pair and with the z-score through a Pearson correlation
(p< 0.05). These analyses were carried using R statistical software version 3.6.3. [24].
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16S rRNA gene profiling
DNA extraction and qPCR amplification. DNA for 16S rRNA sequencing was extracted
from approximately 50–100 mg of unprocessed stool samples using the DNeasy PowerSoil Kit
(Qiagen, Germany) per manufacturer’s instructions. Extraction’s control was performed by
qPCR amplification targeting the V4 region of the 16S rRNA gene.
Library preparation and 16S rDNA sequencing. Samples were sequenced in duplicates
in a single run. The V4 region of the 16S rDNA gene was amplified using tagged primers by
Schloss et al. [25]. using the AccuPrime polymerase blend (Invitrogen, USA). The thermal pro-
tocol of the PCR reaction was composed of an initial denaturation at 95˚C for 5 minutes, fol-
lowed by 30 cycles of 1) denaturation at 95˚C for 15 seconds, 2) primer annealing at 55˚C for
30 seconds and 3) elongation at 68˚C for 1 minute using slow amplification ramp of 1 ˚C per
second to reduce chimera formation. A mock community, a mixture of known microbial
DNA, was processed along with the research samples. The bacterial mock community was an
in-house mixture comprising genomic DNA extracted from cultures of following bacteria,
mixed in uneven ratios and frozen in suitably sized aliquots: Actinomyces odontolyticus, Bur-
kholderia cepacia, Clostridioides difficile, Enterococcus faecalis, Escherichia coli, Listeria mono-
cytogenes, Prevotella denticola, Pseudomonas aeruginosa, Staphylococcus aureus, Staphylococcus
epidermidis, Streptococcus agalactiae, Streptococcus pneumoniae. The correct identification of
the genera (or of species, wherever the V4 region is discriminative) was checked upon comple-
tion of the sequencing run. Amplicon size was checked by agarose gel electrophoresis. Ampli-
fied libraries of the 16S rDNA gene were purified with Ampure magnetic beads on a Biomek
robot (both Beckman Coulter, USA). Purified libraries were then equalized, and pooled.
Equalization was based on quantification by a real-time PCR assay using the KAPA library
quantification kit (Kapa Biosystems, USA). Data from the qPCR machine were processed by a
computer script calculating dilution ratios, and the equalization and pooling was run on a Bio-
mek robot (Beckman Coulter, USA). The final concentration of the pools of 16S rRNA librar-
ies was measured by Qubit dsDNA high-sensitivity assay (Thermo Fisher Scientific, USA).
Sequencing was performed on a MiSeq instrument (Illumina, USA) with the sequencing kit
for 2x 250 base pairs (Ilumina, USA).
16S rDNA data analysis. The ensuing demultiplexed sequencing reads were first trimmed
and filtered by quality, dereplicated to remove redundancy, error rates were estimated, and
true sequences inferred from the pooled sequencing reads of the whole run. Then the read
pairs were merged, chimeras removed, and amplicon sequence variants (i.e. operational taxo-
nomic units) tabulated by samples. Finally, taxonomic assignment was done using the Silva
database version 132. These steps were performed using the DADA2 package [26]. The phylo-
genetic tree was constructed by the neighbour-joining method followed by generalized time-
reversible distances with gamma rate variation implemented in the phangorn package [27].
Sequences classified as chloroplasts, archaea, or cyanobacteria were removed. Subsequently,
the data were converted into a phyloseq object [28] and analyzed.
Alpha-diversity was compared among the N, OW, and OB groups using the Chao1, Simp-
son, Shannon, and ACE indices. Comparisons were carried out under the null assumption
that there was no significant difference (p< 0.05) among the three groups. These were
carried out at the phylum, family, and genus levels via MicrobiomeAnalyst (https://www.
microbiomeanalyst.ca) [29, 30] and phyloseq by using the corresponding taxa total abundance
after cumulative sum scaling. Due to previously observed association of a high Firmicutes/Bac-
teroidetes (F/B) ratio with obesity [6–8], the Ln-transformed F/B ratio derived from the rela-
tive abundance of these two phyla was tested under the hypothesis that there was no
significant difference among the three study groups via a one-way ANOVA (p< 0.05) with
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Tukey’s HSD as a post-hoc procedure using R statistical software version 3.6.3. [24]. For the F/
B ratio, samples 19 (N), 36 (OW), and 29 (OB) were excluded due to extreme values
(� 1.5�IQR) in the Bacteroidetes counts.
Due to the controversial nature of differential abundance analysis in microbiome research
[31, 32] and that no statistical method can fully capture biological phenomena, differential
abundance testing was carried out using two techniques: 1) analysis of composition of micro-
biomes (ANCOM), which has been shown to provide lower false discovery rate (FDR) than
comparable methods [32, 33]; and 2) edgeR, which has also displayed relatively lower FDR
(although higher than ANCOM) and has been recommended for overall performance and
smaller data sets [33–35]. ANCOM was applied to the total abundance table using a signifi-
cance threshold of� 0.8 and was carried out under the null assumption that among the three
different groups there was no significant difference in the relative abundance proportion
between each taxon pair at a specific taxonomic level. It was carried out at five taxonomic lev-
els (genus to phylum) using the script ANCOM v2.1 [36] in R statistical software version 3.6.3.
[24]. EdgeR (significance p� 0.01 after FDR correction) was carried out under the null
hypothesis that taxa were not differentially abundant among the three study groups using
MicrobiomeAnalyst under the following parameters: at least 25% of values having a read
count of 4 or greater, a variance > 10% by IQR throughout the experiment, and cumulative
sum scaling without rarefaction or transformation.
Correlation of metabolomic and 16S rDNA analyses
Resulting significant genera from the differential abundance analysis were evaluated for the
presence and direction of a relationship among themselves and with the significant metabolite
concentrations and the z-score through a correlation test. This was also done globally for all
the identified metabolites and genera. The Spearman correlation test (p< 0.05) was chosen
due to the non-normal distribution of the genus level data despite attempted transformations.
Due to the challenge of zero values in microbial composition [33, 37], a pseudo-count value of
one was added to all read counts, then the relative abundance was derived for analysis. The
analysis was carried out using R statistical software version 3.6.3. [24].
Results
Metabolomic analysis
Multivariate analysis (MVA). PCA did not display clear separation among the N, OW,
and OB groups. The supervised approach using PLS-DA also failed to show clear separation.
Cross-validation Q2 values were negative regardless of the number of principal components,
strongly suggesting that the model lacked predictive power or that it was overfitted. This was
attributed to noise in the data and a relative small sample size.
Univariate analysis (UVA). Sixty-three distinct metabolites were identified through com-
pound deconvolution (Fig 1). One-way ANOVA identified five significantly different com-
pounds among the three groups: butyrate (p = 0.016), arabinose (p = 0.033), galactose
(p = 0.036), trimethylamine (TMA) (p = 0.044), and acetate (p = 0.045). After application of
Tukey HSD post hoc test all compounds, except for acetate (p = 0.063), showed a significant
difference between the N and OB groups and none showed significance between N and OW
and between OW and OB groups. All of these compounds had a higher mean concentration in
the OB group compared to the N group (Fig 2). Application of the false discovery rate (FDR)
for multiple comparisons suggested that only 44% of these five metabolites would be expected
to be significant. Given the study’s sample size and not to discard potentially valuable
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metabolites that may be important for generating further hypotheses, we have included the
metabolites identified through the Tukey HSD test in the Discussion section.
A Pearson correlation of these metabolites between themselves and the z-score showed the
following as significant: z-score with arabinose (p = 0.050, correlation coefficient (cc) = 0.31),
galactose (p = 0.014, cc = 0.38), and TMA (p = 0.016, cc = 0.34); acetate with butyrate
(p< 0.001, cc = 0.73) and TMA (p = 0.004, cc = 0.40); and arabinose with galactose
(p< 0.001, cc = 0.67). These all displayed a positive relationship with the strongest correlations
between acetate with butyrate, and arabinose with galactose.
16S rDNA analysis
A total of 83 genus, 36 family, 19 order, 15 class, and 6 phylum level taxa were identified. Fig 3
is a heatmap based on the phyla’s relative abundance among the participants in the three study
groups. Alpha-diversity assessment at the genus, family, and phylum levels showed no
Fig 1. Representative 1H NMR spectrum. 63 identified metabolites. Compounds in yellow are the five significantly different
(p< 0.05) metabolites based on one-way ANOVA. For visual clarity, with the exception of the five significant metabolites,
compounds are only listed once in the spectra regardless of their actual number of spectral peaks. The water region (4.5 to 5.2 ppm)
has been excluded.
https://doi.org/10.1371/journal.pone.0247378.g001
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significant differences (all p-values > 0.3) among the N, OW, and OB groups. Likewise, the
Firmicutes to Bacteroidetes (F/B) ratio was not significantly different among the three groups
by one-way ANOVA testing.
Differential abundance analysis through ANCOM did not identify any significant taxa at
any of the taxonomic levels, whereas the more permissive EdgeR identified the following sug-
gestive associations: Escherichia (p = 0.005), and Tyzzerella subgroup 3 (p = 0.006) at the genus
level; the signal from Escherichia was reflected also at the family level of Enterobacteriaceae
(p = 0.009). No differential abundance was noted at the order, class, nor phylum levels. Escheri-
chia is one of the main representatives of Enterobateriaceae [38], and both taxa displayed a
similar relative abundance pattern by showing a decrease from the N to the OB group; in con-
trast, Tyzzerella subgroup 3 showed an increase. Fig 4 shows the genera with the highest
Fig 2. Metabolite concentration (mg/g) boxplots. Significantly different (p < 0.05) metabolites among the N, OW, and OB groups
based on one-way ANOVA (significance found only between N and OB groups after post-hoc test. Acetate was not significant after
application of post-hoc test). The x-axis shows the group name and the mean ± standard deviation. The numbers and text in the
graphical area represent: the post-hoc p-value where significant, NS. = not significant, the median and the sample numbers that lie
outside the visible range area.
https://doi.org/10.1371/journal.pone.0247378.g002
Fig 3. Heatmap based on phyla % relative abundance. Warmer colors indicate higher % relative abundance, which was exhibited
by Bacteroidetes and Firmicutes. Cooler colors indicate lower % relative abundance. Inter-individual variability does not display
clear clustering among the three study groups.
https://doi.org/10.1371/journal.pone.0247378.g003
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relative abundances, as well as Escherichia and Tyzzerella subgroup 3. Fig 5 displays the log10
transformed relative abundance for the two significant genera in the three study groups.
Correlation of metabolomic and 16S rDNA analyses
Spearman correlation of the relative abundance of the significant taxa with the concentration
of the significant metabolites and with the z-score did not show any positive significant corre-
lations. Nevertheless, as shown in Table 2, strong positive and negative correlations were
observed among other significant metabolites and non-significant genera, as well as the
reverse. Fig 6 displays the strength of the positive and negative correlations among all identi-
fied genera and metabolites.
Discussion
Our results showed an increase of fecal butyrate in the OB compared to the N group, which
lends support to previous observations of higher short-chain fatty acid (SCFA) concentrations
Fig 4. Stacked bar charts based on genera % relative abundance. Display of the 20 most abundant genera (by relative abundance),
as well as the two significant genera (Escherichia and Tyzzerella subgroup 3) by study group. Genus Other represents the aggregate
of the remaining 61 identified genera.
https://doi.org/10.1371/journal.pone.0247378.g004
Fig 5. Genera relative abundance boxplots. The two genera that displayed significant difference among the N, OW,
and OB groups. The x-axis shows the group name and the mean ± standard deviation, and underneath is the median.
https://doi.org/10.1371/journal.pone.0247378.g005
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in children with overweight/obese compared to those who are normal-weight [8, 39–41]. An
increased SCFA concentration, especially butyrate and acetate, has also been observed in obese
mice when compared to their lean counterparts [42]. Two suggested reasons for this are: 1)
higher substrate fermentation activity by gut microbiota, which translates into increased
microbial energy harvest, and/or 2) decreased absorption due to either low-grade inflamma-
tion, more rapid gut transit time, or shifts in microbial cross-feeding patterns [8, 41, 43].
Given that the diet among the participants in our study was, except for portion size (OW and
OB consumed, on average, 30% fewer kcal than N), approximately homogenous (approx. 17%
protein, 28% fat and 55% carbohydrates), it does suggest higher microbial fermentation activ-
ity from fermentative substrates such as resistant starch and dietary fiber, the main sources of
microbiota-derived SCFAs [5, 8, 44]. Despite consuming less kcal, the OW and OB groups
showed significantly more fecal butyrate, which has been identified as the main energy sup-
plier for colonic epithelial cells [8]. It is common for microbiota produced butyrate to end up
in stool when not consumed by the colonic epithelium [8]. It has been estimated that SCFAs
contribute about 60–70% of the energy requirements of colonic epithelial cells and 5–15% of
the total caloric requirements of humans [45]. A proposed mechanism on how an increase in
butyrate and other SCFAs may increase energy harvest is that SCFAs may serve as substrates
for hepatic de novo lipogenesis (DNL) [42, 46]. The excess non-metabolized SCFAs reach the
liver via the portal system, where they may serve as precursors for gluconeogenesis in case of
propionate, and lipogenesis for acetate and butyrate [47, 48]. Goffredo et al. (2016) in a study
of 84 youth ranging from non-obese to severely obese observed that the three major SCFAs
Table 2. Significant correlations of the significant metabolites with identified genera.





Coprococcus 1 - 0.481
Coprococcus 3 - 0.303
Desulfovibrio - 0.413 - 0.428
Eggerthella - 0.290
Erysipelotrichaceae UCG-003 0.457 0.450
Fusinibacter 0.409
Haemophilus 0.420




Ruminoclostridium 5 - 0.477 - 0.398
Ruminoclostridium 6 - 0.317 - 0.327
Ruminoclostridium 9 - 0.430 - 0.377
Ruminococcaceae NK4A214 - 0.472 - 0.360
Ruminococcaceae UCG-002 - 0.366
Ruminococcaceae UCG-003 - 0.394
Ruminococcaceae UCG-010 - 0.355 - 0.354
Slackia - 0.349
Values are Spearman correlation coefficients. TMA = trimethylamine.
https://doi.org/10.1371/journal.pone.0247378.t002
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were positively associated with body and visceral fat, and from these, butyrate was the only one
significantly associated with hepatic fat; furthermore, when a subset of this group was tested
for associations with DNL, butyrate was significantly associated with a delta increase in hepatic
DNL after a controlled dietary carbohydrate load [46]. The same study, using an in vitro stool
assay, also observed a higher fermentation capability of fructose by youth with obesity com-
pared to nonobese, which further supports the concept of increased energy harvest from food
in those youth with obesity [42, 46]. In looking for the potential instigators of these changes,
the gut microbiota, it is important to keep in perspective that the SCFA-producing microbes
are a phylogenetically diverse group [45], with a wide distribution of enteric bacteria produc-
ing acetate; a much more conservative distribution for butyrate, the most well-known being in
the Firmicutes phylum (Faecalibacterium, Eubacterium, Roseburia); and for propionate several
Firmicutes, Bacteroidetes, and Proteobacteria phyla such as families Veillonellaceae and Lach-
nospiraceae [49–51]. The two significant taxa in our study, Escherichia and Tyzzerella sub-
group 3, were not significantly associated with butyrate; nevertheless, the SCFA was
significantly associated with nine genera (Table 2). Butyrate’s two positive correlations, with
Haemophilus and Roseburia, are supported by several previous studies [7, 49, 50, 52].
Although the higher concentration of SCFAs in children with overweight/obese in several
studies [8, 39–41], including butyrate in ours, could suggest them as an obesity biomarker, this
is not without controversy given that SCFAs are attributed a myriad of health benefits such as,
among others, improvement in blood lipid profiles, glucose homeostasis, and even reduced
body weight [7, 53]. How does one reconcile this contradiction? A potential conceptual anal-
ogy is that of nutrient overload, a certain nutrient amount may confer benefits, but an excess
of it could very well be detrimental. Also, it is important to keep in mind the limitations of
each study; for example, the anti-inflammatory effects of butyrate have been studied mainly in
vitro [45]. In addition, it may be more beneficial to look for biomarkers as part of a panel of
biomarkers instead of individual ones as mentioned by Vignoli et al. (2019) [54].
Fig 6. Metabolite-genus spearman correlation heatmap. The x-axis shows the genera and the y-axis the metabolites.
Warmer colors indicate positive correlations. Cooler colors indicate negative correlations. The more intense the color,
the closer the number is to the Spearman correlation value 1 or -1.
https://doi.org/10.1371/journal.pone.0247378.g006
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In addition to SCFAs, monosaccharides arabinose and galactose also had higher concentra-
tions in our OW and OB groups, and the two monosaccharides displayed a strong positive cor-
relation with each other, and both showed a significant positive correlation with the BMI z-
score. It appears that most monosaccharides in stool often originate from the non-absorbed
breakdown of polysaccharides (resistant starches, dietary fiber), which are the main source of
carbon and energy for the gut microbiota [55], or directly from the diet which can be used as
nutrition by the host’s enzymes [56]. A higher concentration of arabinose and galactose in the
OW and OB groups may suggest an excess of saccharides from the diet or from the breakdown
of polysaccharides which are not absorbed due to energy needs being met without them.
Given the controlled diet of the participants, the results thus suggest the origin to be the poly-
saccharide breakdown. This would directly tie in with the concept of an increased energy har-
vest by the microbial dysbiosis in the obese state [8, 41, 43], which would result in an excess of
monosaccharides as well as a higher load of SCFAs.
Trimethylamine (TMA) also showed higher concentrations in the OW and OB groups. It is
known to be produced by various gut microbiota taxa from dietary quaternary amines, mainly
choline and L-carnitine derived from eggs, milk, liver, red meat, poultry, shell fish and fish
[57–59]. It’s considered toxic due to its further oxidation into trimethylamine N-oxide
(TMAO), which has been associated with atherosclerosis, cardiovascular diseases, and other
ailments [57, 59, 60]. In a previous study, children with obesity showed a decrease of TMA in
fecal water after a diet intervention consisting of rich amounts of non-digestible carbohydrates
[60]. TMA was also shown to be downregulated in the urine of children supplemented with
non-digestible carbohydrates [6, 61]. Other diet induced changes included significant weight
loss, structural microbiota changes, a reduction of serum antigen load, and alleviation of
inflammation [6]. The identified taxa involved in TMA production appear to constitute mem-
bers of the core gut community, though at very low abundances and characterized by func-
tional redundancies indicating that several taxa potentially contribute to the TMA pool [60].
The majority of these were members of the genus Clostridium XIVa and a specific Eubacterium
[60]. This potential is further supported by TMA’s significant positive correlation with acetate
(p = 0.004) and the BMI z-score (p = 0.016).
Genera Escherichia (phylum Proteobacteria), and Tyzzerella subgroup 3 (phylum Firmi-
cutes), were not significantly correlated with our significant metabolites, but they were signifi-
cantly different among the three study groups. In our study, Escherichia decreased in relative
abundance from the N to the OB group. The genus includes both commensal and pathogenic
species, and although species E.coli has been observed to be increased in children with obesity
compared those with normal-weight [62], a general pattern of this genus in relation to child-
hood obesity is still very open to investigation. With Tyzzerella subgroup 3 we observed a rela-
tive abundance increase from the N to the OB group. We could not find any associations
between this taxon and obesity in the literature and, overall, this member of Lachnospiraceae
appears to be of little medical relevance; nevertheless, it has been reported in connection to
dietary variables [63], and one study did observe related genera Tyzzerella and Tyzzerella sub-
group 4 to be enriched in a group of adults with higher cardiovascular disease risk when com-
pared to lower-risk subjects [64]. Even though our 16S rDNA analysis only revealed two
significantly different genera among the three study groups, it is important to point out, espe-
cially for future investigations, that the obese phenotype may be better characterized by the
abundance of several distinct communities rather than by the presence of specific species [46];
furthermore, an alteration in efficiency of energy harvest produced by gut bacterial composi-
tion changes does not have to be great to contribute to obesity given that small changes in
energy balance, over the course of a year, can result in significant changes in body weight [42,
65]. In addition, another possibility is that although inter-group compositional differences
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may be minimal, the differences observed in our metabolite data could rather indicate differ-
ences in bacterial functional activity where metabolically versatile species adapt to changing
nutritional circumstances by selectively metabolizing some substrates to the exclusion of oth-
ers, thus affecting the types and amounts of fermentation products produced from substrates
[55]. An apparent change in microbiota functionality, but not in composition, was observed in
a study my Morales et al. (2016) where a high-fat diet accompanied by fiber supplementation
induced inflammation while not altering gut microbiota composition [66].
In conclusion, our findings suggest support to the hypothesis of increased energy harvest in
obesity by the human gut microbiota through the growing observation of increased fecal buty-
rate in children with overweight/obesity and an increase of certain monosaccharides in the
stool. Also supported is butyrate’s positive correlation with Haemophilus and Roseburia, as
well as the increase of trimethylamine as an indicator of an unhealthy state.
Supporting information
S1 Table. Characteristics of the 52 participants. T1 and T2 refer to one and two days prior to
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pleting this investigation.
Author Contributions
Conceptualization: Andrea Slavı́čková, Karel Černý, Jaroslav Havlı́k.
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